| References |
Top |
| REF 1 |
Fgr but not Syk tyrosine kinase is a target for beta 2 integrin-induced c-Cbl-mediated ubiquitination in adherent human neutrophils. Biochem J. 2003 Mar 1;370(Pt 2):687-94.
|
| REF 2 |
Catalytic domains of tyrosine kinases determine the phosphorylation sites within c-Cbl. FEBS Lett. 2004 Nov 19;577(3):555-62.
|
| REF 3 |
DPP9 is a novel component of the N-end rule pathway targeting the tyrosine kinase Syk. Elife. 2016 Sep 10;5. pii: e16370.
|
| REF 4 |
Beta-chemokine receptor CCR5 signals through SHP1, SHP2, and Syk. J Biol Chem. 2000 Jun 9;275(23):17263-8.
|
| REF 5 |
Expression of dominant-negative src-homology domain 2-containing protein tyrosine phosphatase-1 results in increased Syk tyrosine kinase activity and B cell activation. J Immunol. 1999 Mar 1;162(5):2717-24.
|
| REF 6 |
Differential kinase requirements in human and mouse Fc-gamma receptor phagocytosis and endocytosis. J Leukoc Biol. 2006 Dec;80(6):1553-62.
|
| REF 7 |
Molecular basis for a direct interaction between the Syk protein-tyrosine kinase and phosphoinositide 3-kinase. J Biol Chem. 2005 Jan 14;280(2):1543-51.
|
| REF 8 |
Inhibition of beta 2 integrin receptor and Syk kinase signaling in monocytes by the Src family kinase Fgr. Immunity. 2001 Oct;15(4):507-19.
|
| REF 9 |
Functional interaction between the ubiquitin-specific protease 25 and the SYK tyrosine kinase. Exp Cell Res. 2010 Feb 15;316(4):667-75.
|
| REF 10 |
Tyrosine phosphorylation and complex formation of Cbl-b upon T cell receptor stimulation. Oncogene. 1999 Feb 4;18(5):1147-56.
|
| REF 11 |
Inhibition of CBLB protects from lethal Candida albicans sepsis. Nat Med. 2016 Aug;22(8):915-23.
|
| REF 12 |
Physical and functional association of cortactin with Syk in human leukemic cell line K562. J Biol Chem. 1996 Mar 22;271(12):6631-5.
|
| REF 13 |
Using an in situ proximity ligation assay to systematically profile endogenous protein-protein interactions in a pathway network. J Proteome Res. 2014 Dec 5;13(12):5339-46.
|
| REF 14 |
Requirement of tyrosine-phosphorylated Vav for morphological differentiation of all-trans-retinoic acid-treated HL-60 cells. Cell Growth Differ. 2001 Apr;12(4):193-200.
|
| REF 15 |
Functional and physical interactions of Syk family kinases with the Vav proto-oncogene product. Immunity. 1996 Dec;5(6):591-604.
|
